{"id":"https://openalex.org/W2745652113","doi":"https://doi.org/10.1111/jdv.14527","title":"Topical ionic contra\u2010viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts","display_name":"Topical ionic contra\u2010viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts","alternate_titles":[],"publication_year":2017,"publication_date":"2017-09-06","ids":{"openalex":"https://openalex.org/W2745652113","doi":"https://doi.org/10.1111/jdv.14527","mag":"2745652113","pmid":"https://pubmed.ncbi.nlm.nih.gov/28833595","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5763383"},"language":"en","primary_location":{"id":"doi:10.1111/jdv.14527","doi":"https://doi.org/10.1111/jdv.14527","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.14527","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.14527","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2745652113"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.14527","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010829909","display_name":"Tessa Niemeyer\u2010van der Kolk","orcid":"https://orcid.org/0000-0002-3221-1609","observed_orcids":["https://orcid.org/0000-0002-3221-1609"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. van der Kolk","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113791446","display_name":"Marlous R. Dillingh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.R. Dillingh","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021641306","display_name":"Rianne Rijneveld","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Rijneveld","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082863215","display_name":"Erica Surya Klaassen","orcid":"https://orcid.org/0000-0003-0089-1846","observed_orcids":["https://orcid.org/0000-0003-0089-1846"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E.S. Klaassen","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109038741","display_name":"Maurits N.C. de Koning","orcid":"https://orcid.org/0009-0005-8802-3710","observed_orcids":["https://orcid.org/0009-0005-8802-3710"]},"institutions":[{"id":"https://openalex.org/I4210145914","display_name":"DDL Diagnostic Laboratory","ror":"https://ror.org/04xdr5k48","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210145914"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.N.C. de Koning","raw_affiliation_strings":["DDL Diagnostic Laboratory, Rijswijk, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DDL Diagnostic Laboratory, Rijswijk, The Netherlands","institution_ids":["https://openalex.org/I4210145914"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007477784","display_name":"Stijn T.P. Kouwenhoven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S.T.P. Kouwenhoven","raw_affiliation_strings":["Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337","https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055666566","display_name":"Roel Erik Genders","orcid":"https://orcid.org/0000-0001-8623-9298","observed_orcids":["https://orcid.org/0000-0001-8623-9298"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R.E. Genders","raw_affiliation_strings":["Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337","https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023109735","display_name":"Jan Nico Bouwes Bavinck","orcid":"https://orcid.org/0000-0001-9130-1244","observed_orcids":["https://orcid.org/0000-0001-9130-1244"]},"institutions":[{"id":"https://openalex.org/I121797337","display_name":"Leiden University","ror":"https://ror.org/027bh9e22","country_code":"NL","type":"education","lineage":["https://openalex.org/I121797337"]},{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. N. Bouwes Bavinck","raw_affiliation_strings":["Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands","institution_ids":["https://openalex.org/I121797337","https://openalex.org/I2800006345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059514472","display_name":"Gary L. Feiss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Feiss","raw_affiliation_strings":["Cutanea Life Science, Wayne, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cutanea Life Science, Wayne, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109434078","display_name":"Robert Ri\u00dfmann","orcid":"https://orcid.org/0000-0002-5867-9090","observed_orcids":["https://orcid.org/0000-0002-5867-9090"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"R. Rissmann","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083164288","display_name":"Jacobus Burggraaf","orcid":"https://orcid.org/0000-0001-7912-0918","observed_orcids":["https://orcid.org/0000-0001-7912-0918"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Burggraaf","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5109434078"],"corresponding_institution_ids":["https://openalex.org/I4210133171"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":{"value":5450,"currency":"USD","value_usd":5450},"fwci":1.6538,"has_fulltext":true,"cited_by_count":30,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.77479675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"31","issue":"12","first_page":"2088","last_page":"2090"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.3174000084400177,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.3174000084400177,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10146","display_name":"Cervical Cancer and HPV Research","score":0.3158999979496002,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11172","display_name":"Dermatologic Treatments and Research","score":0.10239999741315842,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/common-warts","display_name":"common warts","score":0.8930000066757202},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":0.7689999938011169},{"id":"https://openalex.org/keywords/furosemide","display_name":"furosemide","score":1.0},{"id":"https://openalex.org/keywords/topical-gel-formulation","display_name":"topical gel formulation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/systemic-exposure","display_name":"systemic exposure","score":0.6729999780654907},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.828000009059906},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8100000023841858},{"id":"https://openalex.org/keywords/sglt1-inhibition","display_name":"SGLT1 inhibition","score":0.5450000166893005},{"id":"https://openalex.org/keywords/sglt2-inhibition","display_name":"SGLT2 inhibition","score":0.9539999961853027}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9699763059616089},{"id":"https://openalex.org/C2777955127","wikidata":"https://www.wikidata.org/wiki/Q388801","display_name":"Furosemide","level":2,"score":0.6550354361534119},{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.6384003758430481},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5536174774169922},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4580253064632416},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.32741183042526245},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22185751795768738},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.054883331060409546}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005665","descriptor_name":"Furosemide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014860","descriptor_name":"Warts","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D049994","descriptor_name":"Sodium Potassium Chloride Symporter Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1111/jdv.14527","doi":"https://doi.org/10.1111/jdv.14527","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.14527","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.14527","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5763383","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5763383/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Eur Acad Dermatol Venereol","raw_type":"Text"},{"id":"pmid:28833595","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28833595","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology : JEADV","raw_type":"Journal Article"},{"id":"pmh:oai:alma.31UKB_LEU:9940751919202711","doi":null,"is_oa":true,"landing_page_url":"https://scholarlypublications.universiteitleiden.nl/handle/1887/115616","pdf_url":"https://scholarlypublications.universiteitleiden.nl/download/1887/115616/1?col=81522199330002711","source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology, Vol. 31, no. 12, p. 2088-2090","raw_type":"http://purl.org/coar/resource_type/c_6501"},{"id":"pmh:oai:openaccess.leidenuniv.nl:1887/115616","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1887/115616","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"31","raw_type":"Article / Letter to editor"},{"id":"pmh:oai:scholarlypublications.universiteitleiden.nl:9940751919202711","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1887/115616","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal article"},{"id":"pmh:oai:scholarlypublications.universiteitleiden.nl:item_3001971","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/1887/115616","pdf_url":null,"source":{"id":"https://openalex.org/S4306400850","display_name":"Leiden Repository (Leiden University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I121797337","host_organization_name":"Leiden University","host_organization_lineage":["https://openalex.org/I121797337"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"Article / Letter to editor"}],"best_oa_location":{"id":"doi:10.1111/jdv.14527","doi":"https://doi.org/10.1111/jdv.14527","is_oa":true,"landing_page_url":"https://doi.org/10.1111/jdv.14527","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.14527","source":{"id":"https://openalex.org/S137740113","display_name":"Journal of the European Academy of Dermatology and Venereology","issn_l":"0926-9959","issn":["0926-9959","1468-3083"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the European Academy of Dermatology and Venereology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2745652113.pdf","grobid_xml":"https://content.openalex.org/works/W2745652113.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1516403474","https://openalex.org/W1964657147","https://openalex.org/W1983535297","https://openalex.org/W1996855623","https://openalex.org/W2013145462","https://openalex.org/W2037044350","https://openalex.org/W2048099212","https://openalex.org/W2074777579","https://openalex.org/W2098045932","https://openalex.org/W2149179336","https://openalex.org/W2150987716","https://openalex.org/W2169406825","https://openalex.org/W2413735129"],"related_works":["https://openalex.org/W2905598692","https://openalex.org/W3140843857","https://openalex.org/W3149844425","https://openalex.org/W4412763365","https://openalex.org/W2969899207","https://openalex.org/W7204440186","https://openalex.org/W2940965505","https://openalex.org/W4408626033","https://openalex.org/W4414058666","https://openalex.org/W4304893399"],"abstract_inverted_index":{"BACKGROUND:":[0],"co-transporter-1,":[1],"respectively).":[2],"We":[3],"therefore":[4],"hypothesized":[5],"that":[6],"these":[7],"two":[8,127],"compounds":[9],"in":[10,17,53,82,176],"a":[11,43,88,208],"topical":[12,51,94],"formulation":[13],"may":[14],"be":[15,195],"valuable":[16],"the":[18,83,182],"treatment":[19,137,206],"of":[20,40,45,65,91,136,150,153,181,204],"HPV-induced":[21],"warts.":[22,57],"This":[23],"new":[24],"approach":[25],"is":[26],"called":[27],"Ionic":[28],"Contra-Viral":[29],"Therapy":[30],"(ICVT).":[31],"OBJECTIVE:":[32],"To":[33],"evaluate":[34,62],"systemic":[35,116,151],"exposure,":[36],"safety":[37,114,162],"and":[38,47,85,100,115,126,145,164,172,179,201],"tolerability":[39],"ICVT":[41,140,191],"with":[42,55,71,87,122],"combination":[44],"furosemide":[46,103],"digoxin":[48,99,154],"after":[49],"repeated":[50],"application":[52],"subjects":[54,70],"common":[56,75],"Furthermore,":[58],"we":[59],"aimed":[60],"to":[61,112,132,194,199,214],"pharmacodynamics":[63],"effects":[64],"ICVT.":[66],"METHODS:":[67],"Twelve":[68],"healthy":[69],"at":[72,187],"least":[73],"four":[74],"warts":[76,119,183],"on":[77,108],"their":[78,109],"hands":[79],"were":[80,120,158],"included":[81],"study":[84],"treated":[86,121],"fixed":[89],"dose":[90],"980":[92],"mg":[93,124],"gel":[95],"containing":[96],"0.125%":[97,101],"(w/w)":[98,102],"for":[104,197],"7":[105,202],"consecutive":[106],"days":[107,203],"lower":[110],"back":[111],"assess":[113],"exposure.":[117],"Two":[118],"10":[123],"each":[125],"served":[128],"as":[129],"negative":[130],"controls":[131],"obtain":[133],"preliminary":[134],"evidence":[135,149],"effect.":[138],"RESULTS:":[139],"was":[141,147,184,192],"well":[142],"tolerated":[143],"topically,":[144],"there":[146],"no":[148,159,165],"exposure":[152],"or":[155],"furosemide.":[156],"There":[157],"clinical":[160],"relevant":[161],"findings":[163],"serious":[166],"adverse":[167],"events":[168],"(SAEs).":[169],"A":[170],"rapid":[171],"statistically":[173],"significant":[174,210],"reduction":[175,212],"diameter,":[177],"height":[178],"volume":[180],"already":[185],"observed":[186],"day":[188],"14.":[189],"CONCLUSION:":[190],"found":[193],"safe":[196],"administration":[198],"humans":[200],"active":[205],"showed":[207],"statistical":[209],"wart":[211],"compared":[213],"untreated":[215],"control":[216],"lesions,":[217],"clearly":[218],"indicating":[219],"pharmacological":[220],"activity.":[221]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2745652113","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2017,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2017-08-31T00:00:00"}
